Basic information
- CAS
153436-54-5- Standard SMILES
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC- InChIKey
LSPANGZZENHZNJ-UHFFFAOYSA-N- Molecular formula
- C16H14BrN3O2
- Average molar mass
- 360.2 g/mol
- Monoisotopic mass
- 359.02693879
Overview
PD-153035 is a member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7. It has a role as an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and an epidermal growth factor receptor antagonist. It is an aromatic amine, an aromatic ether, a member of bromobenzenes, a member of quinazolines and a secondary amino compound. It is a conjugate base of a PD-153035(1+).
Names & identifiers
- Preferred name
- PD-153035
- IUPAC
- N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine
- English name
- PD 153035 hydrochloride
- Molecular formula
- C16H14BrN3O2
- Molecular weight
- 360.21
Names & synonyms
Show more names
Database identifiers
- CAS
153436-54-5- PubChem CID
- 4705
- DTXSID
DTXSID80165328- ChEMBL
CHEMBL29197- ChEBI
CHEBI:91076- UNII
- TC62B68RSL
- EC Number
- 802-811-2
- Nikkaji
- J611.454G
Properties
Computed structural properties
- XLogP
- 4
- Topological polar surface area
- 56.3 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 22
- Formal charge
- 0
- Complexity
- 360
Physicochemical properties
- Melting point
- 189 · 189-190 °C
- Boiling point
- 472.1 · 472.1±45.0 °C(Predicted)
- Density
- 1.499 · 1.499±0.06 g/cm3(Predicted)
- storage temp.
- 2 · Keep in dark place,Inert atmosphere,2-8°C
- solubility
- Soluble in DMSO (up to 5 mg/ml).
- form
- White to off-white solid.
- pka
- 5.55 · 5.55±0.30(Predicted)
- color
- White or off-white
- Stability
- 1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
- InChI
- 1S/C16H14BrN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20)
- InChIKey
- LSPANGZZENHZNJ-UHFFFAOYSA-N
- SMILES
- Brc1cc(ccc1)Nc2ncnc3c2cc(c(c3)OC)OC
- FDA UNII
- 62 B68RSL · TC62B68RSL
- UNSPSC Code
- 12352200 · 12352200
- NACRES
- 77 · NA.77
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 302 · H302-H315-H319-H332-H335
- Precautionary statements
- 261 · P261-P280-P305+P351+P338
- WGK Germany
- 1 · WGK 1
- Storage Class
- 11 · 11 - Combustible Solids
Safety & regulation
GHS classification
GHS Classification
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P264+P265, P270, P280, P301+P316, P305+P354+P338, P317, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard information
Safety data
- wgk
- WGK 1
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- Storage Class
- 11 - Combustible Solids
- Hazard statements
- H302-H315-H319-H332-H335
- Precautionary statements
- P261-P280-P305+P351+P338
Chemistry & industry
Applications
DescriptionAG-1517 HCl (153436-54-5) is an ultra-potent inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR), with an IC50 of 25 pM. Inhibits other tyrosine kinases at micromolar or higher concentrations. It selectively blocks EGF-mediated cellular processes including mitogenesis, early gene expression and oncogenic transformation.1Inhibits the growth of a number of cancer cell lines.2AG-1517 HCl is an extremely useful tool for exploring EGF-mediated cellular signaling.3
UsesPD 153035 is an extremely potent and specific inhibitor of EGFR tyrosine kinase activity.
UsesPD153035 is an inhibitor of EGFR, competitive with ATP. EGF Receptor: IC50 = 25 pM (Ki = 6 pM).
Upstream & downstream products
Upstream raw materials
Downstream products
Suppliers100 total
Additional notes
DefinitionChEBI: A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.
Related reactions
Compound notes
Loading…